NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 206 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,846,492 | -68.9% | 1,084,625 | -58.9% | 0.00% | -66.7% |
Q2 2023 | $67,104,529 | -79.4% | 2,639,832 | -70.7% | 0.01% | -60.0% |
Q1 2023 | $325,414,852 | +58.4% | 9,001,794 | +73.6% | 0.02% | -25.0% |
Q4 2022 | $205,399,379 | +1.2% | 5,186,853 | +19.1% | 0.02% | -4.8% |
Q3 2022 | $202,908,000 | +312.5% | 4,354,248 | +288.0% | 0.02% | +320.0% |
Q2 2022 | $49,189,000 | -55.9% | 1,122,262 | -27.3% | 0.01% | -44.4% |
Q1 2022 | $111,608,000 | +51.3% | 1,543,040 | +69.6% | 0.01% | +80.0% |
Q4 2021 | $73,753,000 | -51.8% | 909,742 | -30.9% | 0.01% | -58.3% |
Q3 2021 | $153,126,000 | -59.3% | 1,315,749 | -42.0% | 0.01% | -58.6% |
Q2 2021 | $376,153,000 | +35.7% | 2,268,845 | +14.2% | 0.03% | +20.8% |
Q1 2021 | $277,255,000 | +11.3% | 1,987,489 | +38.1% | 0.02% | +9.1% |
Q4 2020 | $249,119,000 | +5.6% | 1,439,166 | -15.0% | 0.02% | -8.3% |
Q3 2020 | $235,971,000 | -10.6% | 1,693,978 | -23.3% | 0.02% | -17.2% |
Q2 2020 | $263,848,000 | +221.2% | 2,208,482 | +168.8% | 0.03% | +163.6% |
Q1 2020 | $82,150,000 | +91.4% | 821,660 | +125.1% | 0.01% | +120.0% |
Q4 2019 | $42,914,000 | +476722.2% | 365,100 | +365000.0% | 0.01% | – |
Q3 2019 | $9,000 | +50.0% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $6,000 | -50.0% | 100 | -48.5% | 0.00% | – |
Q3 2018 | $12,000 | -100.0% | 194 | -100.0% | 0.00% | -100.0% |
Q2 2018 | $46,553,000 | +37.0% | 583,000 | +48.7% | 0.01% | +25.0% |
Q1 2018 | $33,975,000 | +30.9% | 392,000 | +37.3% | 0.00% | +33.3% |
Q3 2017 | $25,946,000 | -71.6% | 285,502 | -76.7% | 0.00% | -72.7% |
Q2 2017 | $91,326,000 | -55.8% | 1,227,009 | -44.3% | 0.01% | -57.7% |
Q1 2017 | $206,579,000 | +5.4% | 2,204,685 | -18.2% | 0.03% | 0.0% |
Q4 2016 | $195,930,000 | -54.3% | 2,696,526 | -34.3% | 0.03% | -54.4% |
Q3 2016 | $428,771,000 | +38.8% | 4,107,397 | -1.9% | 0.06% | +35.7% |
Q2 2016 | $308,920,000 | +29.9% | 4,188,187 | -0.9% | 0.04% | +27.3% |
Q1 2016 | $237,824,000 | -1.9% | 4,227,232 | +17.7% | 0.03% | 0.0% |
Q4 2015 | $242,378,000 | +82.0% | 3,590,260 | +25.1% | 0.03% | +73.7% |
Q3 2015 | $133,179,000 | +47.6% | 2,870,850 | +71.0% | 0.02% | +58.3% |
Q2 2015 | $90,250,000 | +112.5% | 1,679,062 | +89.5% | 0.01% | +140.0% |
Q1 2015 | $42,476,000 | +22.9% | 886,200 | -0.8% | 0.01% | +25.0% |
Q4 2014 | $34,552,000 | – | 893,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |